Saurabh Sharma

Dr. Saurabh Sharma

Surgical Oncology, Stanford University School of Medicine, Stanford, California, USA
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Regenerative Biomaterials
Verified
Journal Article
Open access
PDF file
MMMarvin Mecwan
Marvin Mecwan
JLJinghang Li
Jinghang Li
NFNatashya Falcone
Natashya Falcone
MEMenekse Ermis
Menekse Ermis
ETEmily Torres
Emily Torres
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini
Hemorrhage is the leading cause of trauma-related deaths, in hospital and prehospital settings. Hemostasis is a complex mechanism that involves a cascade of clotting factors and proteins that result in the formation of a strong clot. In certain surgical and emergency situations, hemostatic agents are needed to achieve faster blood coagulation to prevent the patient from experiencing a severe hemorrhagic shock. Therefore, it is critical to consider appropriate materials and designs for hemostatic agents. Many materials have been fabricated as hemostatic agents, including synthetic and naturally derived polymers. Compared to synthetic polymers, natural polymers or biopolymers, which include polysaccharides and polypeptides, have greater biocompatibility, biodegradability and processibility. Thus, in this review, we focus on biopolymer-based hemostatic agents of different forms, such as powder, particles, sponges and hydrogels. Finally, we discuss biopolymer-based hemostatic materials currently in clinical trials and offer insight into next-generation hemostats for clinical translation.

1 October 2020 in Acta Biomaterialia
Verified
Journal Article
Closed access
SPSudeep Sudesh Pukale
Sudeep Sudesh Pukale
Saurabh SharmaSaurabh Sharma
Saurabh Sharma
MDManu Dalela
Manu Dalela
ASArihant Kumar Singh
Arihant Kumar Singh
SMSujata Mohanty
Sujata Mohanty
DCDeepak Chitkara
Deepak Chitkara

17 August 2022 in Small
Verified
Journal Article
Closed access
SKSatoru Kawakita
Satoru Kawakita
KMKalpana Mandal
Kalpana Mandal
LMLei Mou
Lei Mou
MMMarvin Magan Mecwan
Marvin Magan Mecwan
YZYangzhi Zhu
Yangzhi Zhu
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini

25 August 2022 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
LMLei Mou
Lei Mou
KMKalpana Mandal
Kalpana Mandal
MMMarvin Magan Mecwan
Marvin Magan Mecwan
AHAna Lopez Hernandez
Ana Lopez Hernandez
SMSurjendu Maity
Surjendu Maity
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini
Microphysiological systems (MPSs), also known as organ-on-a-chip models, aim to recapitulate the functional components of human tissues or organs in vitro. Over the last decade, with the advances in biomaterials, 3D bioprinting, and microfluidics, numerous MPSs have emerged with applications to study diseased and healthy tissue models. Various organs have been modeled using MPS technology, such as the heart, liver, lung, and blood–brain barrier. An important aspect of in vitro modeling is the accurate phenotypical and functional characterization of the modeled organ. However, most conventional characterization methods are invasive and destructive and do not allow continuous monitoring of the cells in culture. On the other hand, microfluidic biosensors enable in-line, real-time sensing of target molecules with an excellent limit of detection and in a non-invasive manner, thereby effectively overcoming the limitation of the traditional techniques. Consequently, microfluidic biosensors have been increasingly integrated into MPSs and used for in-line target detection. This review discusses the state-of-the-art microfluidic biosensors by providing specific examples, detailing their main advantages in monitoring MPSs, and highlighting current developments in this field. Finally, we describe the remaining challenges and potential future developments to advance the current state-of-the-art in integrated microfluidic biosensors.

1 October 2019 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
PHP.J. Harsha
P.J. Harsha
NTNagarani Thotakura
Nagarani Thotakura
MKManish Kumar
Manish Kumar
Saurabh SharmaSaurabh Sharma
Saurabh Sharma
AMAnupama Mittal
Anupama Mittal
KRKaisar Raza
Kaisar Raza

10 May 2018 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
Saurabh SharmaSaurabh Sharma
Saurabh Sharma
SMSamrat Mazumdar
Samrat Mazumdar
KIKishan S. Italiya
Kishan S. Italiya
TDTushar Date
Tushar Date
RMRam I. I Mahato
Ram I. I Mahato
DCDeepak Chitkara
Deepak Chitkara